Compare Novartis AG (NVS) vs Valero Energy Corporation (VLO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novartis AG vs Valero Energy Corporation — how do they compare? Novartis AG trades at $142.74 (market cap $274.00B), while Valero Energy Corporation trades at $440.51 (market cap $122.11B). The key difference: Novartis AG is far larger — about 2.2× Valero Energy Corporation's market cap, and Novartis AG pays the higher dividend (3.31%). Which is the better fit depends on your goals — on Pluang, investors hold Novartis AG for 82 Days and Valero Energy Corporation for 56 Days on average.
| NVS | VLO | |
|---|---|---|
Market Cap | $274.00B | $122.11B |
Volume | 1,852,137 | 1,826,747 |
Sector | Health | Energy |
52-Week High | $168.62 | $443.80 |
52-Week Low | $121.80 | $156.39 |
Typical Hold Time | 82 Days | 56 Days |
Enterprise Value | $315.32B | $125.59B |
Dividend Yield | 3.31% | 1.13% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Novartis (NVS) trades at $143.11, up 1.65% with mixed technical signals showing neutral momentum. The company maintains strong profitability with 22.5% net margins and recently announced a $7.8B licensing deal with China's Abogen. Recent earnings show two beats and one miss in the last three quarters, with Q3 2026 results pending. The stock trades below the consensus price target of $146, suggesting modest upside potential from current levels.
Novartis presents a balanced investment case with strong cash flow generation and profitability offset by recent clinical setbacks and M&A scrutiny. The $7.8B Abogen partnership expands the autoimmune pipeline, but investors face risks from patent cliffs and drug development failures. Analyst consensus leans cautious with 68% hold ratings, reflecting uncertainty around pipeline execution amid ongoing strategic repositioning.
Valero Energy (VLO) trades at $424.10, up 1.16% with strong technical momentum and bullish moving averages. The company has beaten earnings estimates for three consecutive quarters, though revenue has declined from $176.4B in 2022 to $122.7B in 2025. Analyst consensus remains positive with 57% buy ratings, though the current price exceeds the $408.10 consensus target. Recent news highlights refining sector strength and institutional buying interest.
VLO presents a mixed outlook with strong operational performance offset by revenue pressures. The stock's premium valuation (P/E 17.69) and overbought RSI suggest near-term caution, but projected 2026 earnings growth ($7.2B net income) and dividend yield provide support. Key risks include refining margin volatility and potential policy impacts from diesel export restrictions.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novartis AG
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →About Valero Energy Corporation
Valero Energy is one of the largest independent refiners in the United States. It operates 14 refineries with a total throughput capacity of 3.2 million barrels a day in the United States, Canada, and the United Kingdom. Valero also owns 14 ethanol plants with capacity of 1.7 billion gallons of ethanol a year and holds a 50% stake in Diamond Green Diesel, which has capacity to produce 700 million gallons per year of renewable diesel.
Read more on VLO →
